Objective: No universal definition for treatment-resistant depression (TRD) exists. This lack
of consensus reduces the generalizability of study findings and limits the ability to study …

BACKGROUND: The multiple factors likely to influence estimates of the prevalence of
bipolar spectrum disorders (BSD) make it difficult to determine its actual prevalence. A …

Abstract Background and Objectives Bipolar disorder (BD) may result in a greater burden
than all forms of cancer, Alzheimer's disease and epilepsy. Cost-of-illness (COI) studies …

Objective: Converging lines of evidence indicate that defects in the mitochondrial electron
transport chain (ETC) are associated with bipolar disorder (BD), and that mood-stabilizing …

The social disruption experienced by people with neuropsychiatric disorders may be
pervasive and manifest in divorce. It has been estimated that 90% of marriages involving a …

Introduction: Biospecimens are tools that have the potential to improve early identification
and treatment for autism spectrum disorders (ASD) and bipolar disorders (BPD) …

Résumé Cette étude, réalisée auprès d'un échantillon de convenance de 71 familles de
personnes souffrant de schizophrénie, explore au moyen d'analyses de régression, les liens …

Atypical antipsychotics have been increasingly shown to have efficacy in the treatment of
various phases of bipolar disorder. Ziprasidone acts primarily through serotonergic and …

Carbamazepine (CBZ) has long been a therapeutic option for bipolar disorder.
Carbamazepine extended-release capsules (CBZ-ERC) are a recent formulation of CBZ …

Dr. Knoth is a senior research scientist in the pharmacoeconomics and health outcomes
research group at Prescription Solutions, 3515 Harbor Boulevard, Costa Mesa, California …